Federal Register / Vol. 76, No. 2 / Tuesday, January 4, 2011 / Notices 367 

Authority: Section 1420 of the Safe 

Drinking Water Act, as amended (1996), and 

40 CFR Part 142 of the National Primary 

Drinking Water Regulations. 

Dated: December 22, 2010. 

Dennis J. McLerran, 

Regional Administrator, Region 10. 

[FR Doc. 2010–33192 Filed 1–3–11; 8:45 am] 

BILLING CODE 6560–50–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES (HHS) 

Centers for Disease Control and 

Prevention (CDC) 

Office of State, Tribal, Local and 

Territorial Support (OSTLTS) 

In accordance with Presidential 

Executive Order No. 13175, November 

6, 2000, and the Presidential 

Memorandum of November 5, 2009 and 

September 23, 2004, Consultation and 

Coordination with Indian Tribal 

Governments, CDC, OSTLTS announces 

the following meeting and Tribal 

Consultation Session: 

Name: Tribal Consultation Advisory 

Committee (TCAC) Meeting and 6th Biannual 

Tribal Consultation Session 

Times and Dates: 

8:30 a.m.–5 p.m., February 1–2, 2011 (TCAC 

Meeting) 

8:30 a.m.–5 p.m., February 3, 2011 (6th 

Biannual Tribal Consultation Session) 

Place: CDC, 1600 Clifton Road, NE., 

Building 21, Atlanta, Georgia 30333. 

Status: The TCAC meeting is open to the 

public. Attendance at the Tribal Consultation 

meeting is by special invitation to the 

American Indian/Alaska Native (AI/AN) 

Tribal Leaders from across the nation. 

Visitors must be processed in accordance 

with established federal policies and 

procedures. All visitors are required to 

present a valid form of picture identification 

issued by a state or federal government. The 

meeting room accommodates approximately 

100 people. 

Purpose: CDC released their Tribal 

Consultation Policy in October of 2005 with 

the primary purpose of providing guidance 

across the agency to work effectively with AI/ 

AN tribes, communities, and organizations to 

enhance AI/AN access to CDC resources and 

programs. In November of 2006, an Agency 

Advisory Committee (CDC/Agency for Toxic 

Substances and Disease Registry Tribal 

Consultation Advisory Committee—TCAC) 

was established to provide a complementary 

venue wherein tribal representatives and 

CDC staff have the opportunity to exchange 

information about public health issues in 

Indian Country, identifying urgent public 

health needs in AI/AN communities, and 

discuss collaborative approaches to these 

issues and needs. Within the CDC 

Consultation Policy, it is stated that CDC will 

conduct government-to-government 

consultation with elected tribal officials or 

their designated representatives and also 

confer with AI/AN organizations and AI/AN 

urban and rural communities before taking 

actions and or making decisions that affect 

them. Consultation is designed to be an 

enhanced form of communication that 

emphasizes trust, respect, and shared 

responsibility. It is an open and free 

exchange of information and opinion among 

parties that leads to mutual understanding 

and comprehension. CDC believes that 

consultation is integral to a deliberative 

process that results in effective collaboration 

and informed decision making with the 

ultimate goal of reaching consensus on 

issues. Although formal responsibility for the 

agency’s overall government-to-government 

consultation activities rests within the 

OSTLTS, leadership of other CDC Centers, 

Institutes and Offices shall actively 

participate in TCAC meetings and HHSsponsored regional and national tribal 

consultation sessions as frequently as 

possible. 

Matters to be Discussed: The TCAC will 

convene their advisory committee meeting 

with discussions and presentations by 

various CDC senior leaders on activities and 

areas identified by TCAC members and other 

tribal leaders as priority public health issues. 

The Biannual Tribal Consultation Session 

will engage CDC Senior leadership from the 

Office of the Director and various CDC 

Centers, Institutes and Offices. Opportunities 

will be provided during the consultation 

session for tribal testimony. Tribal Leaders 

are encouraged to submit written testimony 

by close of business on January 15, 2011, to 

the contact person listed below. 

It may be necessary to limit the time of 

each presenter due to the availability of time. 

The agenda is subject to change as 

priorities dictate. 

Information on previous TCAC and Tribal 

Consultation meetings is available at web 

link http://www.cdc.gov/ostlts/ 

tribal_public_health/index.html. 

Contact Person for More Information: 

Kimberly Cantrell, Senior Tribal Liaison for 

Policy and Evaluation, OSTLTS, CDC, 4770 

Buford Highway, MS E–19, Atlanta, Georgia 

30341, telephone (404) 498–0411, e-mail: 

KLW6@cdc.gov. 

The Director, Management Analysis and 

Services Office has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention, and the Agency for Toxic 

Substances and Disease Registry. 

Dated: December 27, 2010. 

Andre Tyler, 

Acting Director, Management Analysis and 

Services Office Centers for Disease Control 

and Prevention. 

[FR Doc. 2010–33126 Filed 1–3–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Minority HIV/ 

AIDS Research Initiative (MARI) To 

Build Capacity in Black and Hispanic 

Communities and Among Black and 

Hispanic Researchers To Conduct HIV/ 

AIDS Epidemiologic and Prevention 

Research, Funding Opportunity 

Announcement (FOA), PS11–003, 

Initial Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Times and Dates: 

8 a.m.–5 p.m., March 14, 2011 

(Closed) 

8 a.m.–5 p.m., March 15, 2011 

(Closed) 

Place: Sheraton Gateway Hotel 

Atlanta Airport, 1900 Sullivan Road, 

Atlanta, Georgia 30337, Telephone: 

(770)997–1100. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in Section 552b(c) 

(4) and (6), Title 5 U.S.C., and the 

Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92– 

463. 

Matters to be Discussed: The meeting 

will include the initial review, 

discussion, and evaluation of 

applications received in response to 

‘‘Minority HIV/AIDS Research Initiative 

(MARI) to Build Capacity in Black and 

Hispanic Communities and Among 

Black and Hispanic Researchers to 

Conduct HIV/AIDS Epidemiologic and 

Prevention Research, FOA PS11–003, 

initial review.’’ 

Contact Person for More Information: 

Amy Yang, Ph.D., Scientific Review 

Officer, CDC, 1600 Clifton Road, NE., 

Mailstop E60, Atlanta, Georgia 30333, 

Telephone: (404) 498–2733. The 

Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 


jlentini on DSKJ8SOYB1PROD with NOTICES
368 Federal Register / Vol. 76, No. 2 / Tuesday, January 4, 2011 / Notices 

Dated: December 20, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–33124 Filed 1–3–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–N–0296] 

Agency Information Collection 

Activities; Announcement of Office of 

Management and Budget Approval; 

Food Labeling Regulations 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a collection of information entitled 

‘‘Food Labeling Regulations’’ has been 

approved by the Office of Management 

and Budget (OMB) under the Paperwork 

Reduction Act of 1995. 

FOR FURTHER INFORMATION CONTACT: 

Denver Presley, Jr., Office of Information 

Management, Food and Drug 

Administration, 1350 Piccard Dr., PI50– 

400B, Rockville, MD 20850, 301–796– 

3793. 

SUPPLEMENTARY INFORMATION: In the 

Federal Register of July 15, 2010 (75 FR 

41207), the Agency announced that the 

proposed information collection had 

been submitted to OMB for review and 

clearance under 44 U.S.C. 3507. An 

Agency may not conduct or sponsor, 

and a person is not required to respond 

to, a collection of information unless it 

displays a currently valid OMB control 

number. OMB has now approved the 

information collection and has assigned 

OMB control number 0910–0381. The 

approval expires on December 31, 2013. 

A copy of the supporting statement for 

this information collection is available 

on the Internet at http:// 

www.reginfo.gov/public/do/PRAMain. 

Dated: December 27, 2010. 

David Dorsey, 

Acting Deputy Commissioner for Policy, 

Planning and Budget. 

[FR Doc. 2010–33212 Filed 1–3–11; 8:45 am] 

BILLING CODE 4160–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2010–N–0374] 

Agency Information Collection 

Activities; Announcement of Office of 

Management and Budget Approval; 

Petition To Request an Exemption 

From 100 Percent Identity Testing of 

Dietary Ingredients; Current Good 

Manufacturing Practice in 

Manufacturing, Packaging, Labeling, or 

Holding Operations for Dietary 

Supplements 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a collection of information entitled 

‘‘Petition to Request an Exemption From 

100 Percent Identity Testing of Dietary 

Ingredients; Current Good 

Manufacturing Practice in 

Manufacturing, Packaging, Labeling, or 

Holding Operations for Dietary 

Supplements’’ has been approved by the 

Office of Management and Budget 

(OMB) under the Paperwork Reduction 

Act of 1995. 

FOR FURTHER INFORMATION CONTACT: 

Denver Presley, Jr., Office of Information 

Management, Food and Drug 

Administration, 1350 Piccard Dr., PI50– 

400B, Rockville, MD 20850, 301–796– 

3793. 

SUPPLEMENTARY INFORMATION: In the 

Federal Register of September 30, 2010 

(75 FR 60463), the Agency announced 

that the proposed information collection 

had been submitted to OMB for review 

and clearance under 44 U.S.C. 3507. An 

Agency may not conduct or sponsor, 

and a person is not required to respond 

to, a collection of information unless it 

displays a currently valid OMB control 

number. OMB has now approved the 

information collection and has assigned 

OMB control number 0910–0608. The 

approval expires on December 31, 2013. 

A copy of the supporting statement for 

this information collection is available 

on the Internet at http:// 

www.reginfo.gov/public/do/PRAMain. 

Dated: December 27, 2010. 

David Dorsey, 

Acting Deputy Commissioner for Policy, 

Planning and Budget. 

[FR Doc. 2010–33209 Filed 1–3–11; 8:45 am] 

BILLING CODE 4160–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2010–N–0373] 

Agency Information Collection 

Activities; Announcement of Office of 

Management and Budget Approval; 

Preparing a Claim of Categorical 

Exclusion or an Environmental 

Assessment for Submission to the 

Center for Food Safety and Applied 

Nutrition 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a collection of information entitled 

‘‘Preparing a Claim of Categorical 

Exclusion or an Environmental 

Assessment for Submission to the 

Center for Food Safety and Applied 

Nutrition’’ has been approved by the 

Office of Management and Budget 

(OMB) under the Paperwork Reduction 

Act of 1995. 

FOR FURTHER INFORMATION CONTACT: 

Denver Presley, Jr., Office of Information 

Management, Food and Drug 

Administration, 1350 Piccard Dr., PI50– 

400B, Rockville, MD 20850. 301–796– 

3793. 

SUPPLEMENTARY INFORMATION: In the 

Federal Register of September 28, 2010 

(75 FR 59722), the Agency announced 

that the proposed information collection 

had been submitted to OMB for review 

and clearance under 44 U.S.C. 3507. An 

Agency may not conduct or sponsor, 

and a person is not required to respond 

to, a collection of information unless it 

displays a currently valid OMB control 

number. OMB has now approved the 

information collection and has assigned 

OMB control number 0910–0541. The 

approval expires on December 31, 2013. 

A copy of the supporting statement for 

this information collection is available 

on the Internet at http:// 

www.reginfo.gov/public/do/PRAMain. 

Dated: December 27, 2010. 

David Dorsey, 

Acting Deputy Commissioner for Policy, 

Planning and Budget. 

[FR Doc. 2010–33210 Filed 1–3–11; 8:45 am] 

BILLING CODE 4160–01–P 


jlentini on DSKJ8SOYB1PROD with NOTICES